The Chemotherapy of Human Malignant Melanoma

Platinum coordination complexes in cancer chemotherapy

1973 • 379 citations

Human Malignant Melanoma.

1980 • 287 citations

Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962.

1965 • 216 citations

Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878).

1969 • 216 citations

High-dose cyclophosphamide therapy for malignant disease.Toxicity, tumor response, and the effects of stored autologous marrow

1972 • 207 citations

Human Malignant Melanoma

1979 • 189 citations

Treatment of malignant melanoma with camptothecin (NSC-100880).

1972 • 158 citations

Clinical studies on triethylenephosphoramide and diethylenephosphoramide, compounds with nitrogen-mustard-like activity

1953 • 98 citations

Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma

1971 • 94 citations

A Methylhydrazine Derivative in Hodgkin's Disease and Other Malignant Neoplasms

1965 • 89 citations

BCNU (1,3), BIS(B-chloroethyl)-1-nitrosourea. Effects on advanced Hodgkin's disease and other neoplasia

1968 • 80 citations

Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).

1970 • 77 citations

Vinblastine in Neoplastic Disease Midwest Cooperative Chemotherapy Group

1963 • 72 citations

CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study

1973 • 70 citations

Combination chemotherapy for disseminated malignant melanoma

1975 • 66 citations

Clinical studies on the carcinolytic action of triethylenephosphoramide

1953 • 65 citations

Toxicity and Antitumor Effect Of Divided Doses of Methotrexate

1965 • 65 citations

Initial clinical studies with vincristine.

1962 • 62 citations

Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea

1972 • 60 citations

Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma

1977 • 50 citations

Clinical experience with mitomycin C in large infrequent doses

1972 • 49 citations

The chemotherapeutic effects and complications of actinomycin D in patients with advanced cancer

1958 • 48 citations

Re-evaluation of methotrexate as an anticancer drug.

1967 • 47 citations

DTIC and combination therapy for melanoma

1981 • 47 citations

DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).

1976 • 47 citations

Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.

1976 • 43 citations

A phase II study of methyl CCNU in the treatment of solid tumors and lymphomas: A Southwest oncology group study

1975 • 40 citations

Clinical studies of vinblastine.

1961 • 40 citations

Eastern Cooperative Oncology Group studies with DTIC (NSC-45388).

1976 • 40 citations

Hodgkin's disease, carcinoma of the breast, and other tumors treated with vinblastine sulfate.

1962 • 37 citations

Further comparative trial of triethylene thiophosphoramide and mechlorethamine in patients with Melanoma and Hodgkin's disease

1964 • 36 citations

Effects of mitomycin c (NSC-26980) in 346 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.

1968 • 36 citations

Clinical experience with mitomycin C (NSC-26980).

1970 • 36 citations

Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma

1977 • 36 citations

Evaluation of l-(2-chloroethyl-3-4-methylcyclohexyl)-l-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45388) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma

1974 • 34 citations

A prelusive clinical trial of cyclophosphamide.

1960 • 34 citations

Preliminary clinical studies with ibenzmethyzin

1966 • 34 citations

Evaluation of VP-16-213 in malignant lymphoma and melanoma.

1978 • 34 citations

Effects of chlorambucil (NSC-3088) in 374 patients with advanced cancer. Eastern Clinical Drug Evualuation Program.

1968 • 34 citations

Chemotherapy of Malignant Melanoma with Dimethyl Triazeno lmidazole Carboxamide (DITC) and Nitrosourea Derivatives (BCN U, CCNU)

1974 • 33 citations

CLINICAL EVALUATION OF VINCRISTINE (NSC-67574).

1964 • 32 citations

Clinical experience with vincristine (NSC-67574) in tumors of the central nervous system and other malignant diseases.

1968 • 31 citations

DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristine.

1979 • 30 citations

CLINICAL EXPERIENCE WITH VINBLASTINE SULFATE (NSC-49842) IN SQUAMOUS CELL CARCINOMA AND OTHER MALIGNANCIES.

1964 • 30 citations

Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanoma.

1972 • 26 citations

Phase II study of dibromodulcitol (NSC-104800).

1974 • 25 citations

Treatment of malignant melanoma with methyl CCNU

1974 • 25 citations

STUDIES OF PHENYLALANINE NITROGEN MUSTARD (CB 3025) IN METASTATIC MALIGNANT MELANOMA OF MAN

1958 • 25 citations

Preliminary studies with cyclophosphamide.

1960 • 24 citations

Treatment of leukemia, lymphoma, and other malignant neoplasms with Vinblastine.

1961 • 23 citations

The antitumor spectrum of cyclophosphamide.

1962 • 23 citations

Phase II evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in patients with solid tumors.

1972 • 23 citations

Intensive cyclophosphamide (NSC-26271) therapy for solid tumors.

1975 • 22 citations

Induced remission of malignant melanoma with actinomycin D.Immunologic implications

1967 • 20 citations

A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma.

1972 • 20 citations

Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma.

1976 • 20 citations

The influence of cyclophosphamide upon neoplastic diseases in man.

1960 • 19 citations

1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU, NSC-79037): A comparison of drug administration at four-week and six-week intervals

1973 • 19 citations

Treatment of malignant melanoma with hydroxyurea.

1967 • 18 citations

Oral Melphalan Therapy in Advanced Malignant Disease

1963 • 18 citations

A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878).

1970 • 17 citations

TRIETHYLENEPHOSPHORAMIDE IN THE TREATMENT OF DISSEMINATED MELANOMA

1958 • 17 citations

EXPERIENCE WITH VINCRISTINE IN SOLID TUMORS.

1963 • 17 citations

Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma

1976 • 17 citations

Vincaleukoblastine. IV. A summary of two and one-half years' experience in the use of vinblastine.

1962 • 15 citations

The Treatment of Advanced Malignant Melanoma

1958 • 15 citations

Hydroxyurea (NSC-32065) intermittent therapy in malignant diseases.

1969 • 15 citations

The chemotherapy of malignant melanoma.

1968 • 14 citations

Improved systemic chemotherapy for malignant melanoma

1971 • 13 citations

Clinical and biochemical studies of high-dose intermittent therapy of solid tumors with hydroxyurea (NSC-32065).

1970 • 13 citations

Effects of 6-mercaptopurine (NSC-755) in 290 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.

1968 • 13 citations

Pilot study of vinblastine and bleomycin combinations in the treatment of metastatic melanoma.

1980 • 13 citations

HYDROXYUREA (NSC-32065)--A PHASE I STUDY.

1964 • 12 citations

Positive phase II trial of dibromodulcitol in patients with metastatic melanoma refractory to DTIC and a nitrosourea.

1978 • 12 citations

VINCRISTINE (NSC-67574) THERAPY OF ADULT PATIENTS WITH SOLID TUMORS.

1964 • 12 citations

Cyclophosphamide, vincristine and procarbazine in the treatment of malignant melanoma

1976 • 12 citations

Neoplastic Disease

1965 • 12 citations

Dose-schedule studies with hydroxyurea (NSC-32065) in malignant melanoma.

1971 • 11 citations

6-mercaptopurine (NSC-755) given intravenously at weekly intervals to patients with advanced cancer.

1967 • 11 citations

Treatment of neoplastic diseases with an improved oral preparation of vinblastine sulfate

1966 • 11 citations

Phase II study of subcutaneously administered 5‐azacytidine (NSC‐102816) in patients with metastatic malignant melanoma

1978 • 11 citations

Phase II trial of pyrazofurin in malignant melanoma.

1977 • 10 citations

Initial experiences with methylhydrazine, a new cytotoxic agent

1966 • 9 citations

Phase II trial of VM-26 in patients with metastatic malignant melanoma.

1978 • 9 citations

Cyclocytidine chemotherapy for malignant melanoma.

1978 • 7 citations

An evaluation of large intermittent intravenous doses of cyclophosphamide (NSC-26271) in the treatment of metastatic malignant melanoma.

1970 • 7 citations

Clinical experiences with dibromodulcitol (NSC-104800) in solid tumors.

1971 • 7 citations

High-dose methotrexate in malignant melanoma.

1979 • 7 citations

CLINICAL RESULTS WITH HYDROXYUREA IN CANCER CHEMOTHERAPY; PRELIMINARY REPORT.

1965 • 7 citations

Use of combination chemotherapy with CCNU, bleomycin, and vincristine in the treatment of metastatic melanoma in patients resistant to DTIC therapy.

1979 • 7 citations

Phase II trial of piperazinedione in malignant melanoma: a report by the Southeastern Cancer Study Group.

1979 • 7 citations

Piperazinedione in patients with advanced malignant melanoma: a Southwest Oncology Group study.

1978 • 5 citations

Treatment of advanced neoplastic disease with 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037).

1973 • 5 citations

Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.

1974 • 4 citations

Treatment of solid tumors and lymphomas with methyl-CCNU (NSC-95441): a phase II study.

1975 • 4 citations

Clinical evaluation of asaley

1977 • 4 citations

6-Mercaptopurine (NSC-755) given intermittently in high doses: phase II study.

1970 • 4 citations

Single reversal trial of hydroxyurea (NSC-32065) in 91 patients with advanced cancer.

1970 • 4 citations

Deleted Work

1955 • 0 citations